RxDoctor Payments Data

Brian Tedesco

Podiatrist · Somerville, MANPI 1588628853

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,383 of the $2,210 with a category attached, or 62.6%. 22 manufacturers reported payments, led by Treace Medical Concepts, Inc. at 29.7% of the total. Reporting peaked in 2023 at $1,514 and has fallen 85.2% since, to $224 in 2025.

$2,210in general payments, 2019–2025

Across 52 payments — averaging $42.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Treace Medical Concepts, Inc.$657
  • Arthrex$278
  • Organogenesis Inc.$229
  • Smith+Nephew$217
  • DJO, LLC$124
  • Medshape, Inc.$111
  • plus $596 from 16 others

What the payments were for

  • Travel & lodging$70732%
  • Food & beverage$1,38363%
  • Education$1095%
  • Entertainment$111%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,210 in reported general payments places this provider in the 75th percentile of 179 podiatrist providers in Massachusetts.

See all podiatrist providers in Massachusetts

Medicare billing

Part B allowed, 2024
$89,108
Medicare patients
195
Services billed
2,126

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cephalexin23$138
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen11$41

Paid to pharmacies, not to this prescriber.

Other podiatrist in Somerville

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →